SEC Form 4 · accession 0001140361-16-066565
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Marvin L White
Director
Period of report
May 18, 2016
Accepted (ET)
May 20, 2016 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 18, 2016 | D | 7,833 | $0.00 | D | 22,467 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of unvested restricted stock units forfeited due to resignation.
- F2The total number of shares has been reduced by 7,833 as a result of the Reporting Person's resignation from the Emergent Board of Directors in connection with his being named as prospective Chief Executive Officer of Aptevo, an entity being spun-off from Emergent.